SEC Filing Summary: GSK Plc (Form 6-K)
Business Context and Reporting Period
This Form 6-K filing by GSK Plc, dated December 17, 2025, reports a transaction in the company's own shares. The filing details a share repurchase executed on December 16, 2025, acting through BNP Paribas SA as the broker. The transaction is part of an existing buyback programme established under a non-discretionary agreement announced on September 30, 2025.
Key Financial Metrics and Transaction Details
The filing focuses exclusively on capital structure changes via share repurchase rather than operational financial performance. Key metrics for the reported transaction include:
- Shares Purchased: 230,000 ordinary shares.
- Price Range: Lowest price paid was 1,816.50 GBp; highest price paid was 1,850.00 GBp.
- Average Price: Volume-weighted average price paid was 1,834.71 GBp.
- Trading Venues: Purchases were executed across BATE, CHIX, and XLON.
Since the programme's inception on September 30, 2025, the Company has purchased a total of 13,851,733 ordinary shares. Following this transaction, GSK holds 239,316,577 ordinary shares in treasury. The total number of ordinary shares in issue (excluding treasury shares) is 4,076,124,506.
Material Changes and Capital Structure
The primary material change reported is the reduction of shares in issue and the increase in treasury holdings. The percentage of voting rights attributable to ordinary shares held in treasury is now 5.87%. The total number of voting rights in the Company remains 4,076,124,506. This figure serves as the denominator for shareholders calculating notification requirements under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no new operational guidance, revenue outlook, or management commentary regarding business performance. It includes a standard cautionary statement regarding forward-looking statements, noting that actual results may differ materially from projections due to risks described in the 2024 Annual Report on Form 20-F and the Q3 2025 Results.
Investor Verification Checklist
- Verify the total number of shares in issue (4,076,124,506) for accurate calculation of ownership percentages.
- Confirm the treasury share percentage (5.87%) to assess voting rights dilution.
- Review the cumulative buyback volume (13,851,733 shares since Sept 30, 2025) to gauge the remaining capacity of the current programme.
- Note that this filing does not contain revenue, profit, or cash flow data; refer to the most recent Form 20-F or quarterly results for operational metrics.